NewcelX Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-8.3	-7.2	-3.33
Depreciation & Amortization	0.06	0.41	0.62
Stock-Based Compensation	0.77	0.21	0.15
Other Adjustments	5.78	4.77	-0.12
Changes in Accounts Payable	-0.58	0.04	-0.48
Changes in Accrued Expenses	-0.29	0.38	-0.12
Changes in Other Operating Activities	-0.2	0.32	-0.17
Operating Cash Flow	-2.77	-1.07	-3.44
Capital Expenditures	-0.01	-0.01	-0.01
Sale of Property, Plant & Equipment	-	-	0.11
Other Investing Activities	1.71	-	-
Investing Cash Flow	1.7	-0.01	0.1
Long-Term Debt Issued	0.29	0.45	1.24
Net Long-Term Debt Issued (Repaid)	0.29	0.45	1.24
Issuance of Common Stock	2.34	-	1.61
Net Common Stock Issued (Repurchased)	2.34	-	1.61
Financing Cash Flow	2.63	0.45	2.85
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.01	-0.04	-0.17
Net Cash Flow	1.55	-0.67	-0.66
Free Cash Flow	-2.77	-1.07	-3.45
Free Cash Flow Per Share	-0.72	-0.36	-1.17
Levered Free Cash Flow	-9.03	-5.6	-2.24
Unlevered Free Cash Flow	-3.59	-0.92	-3.17